Title |
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2013
|
DOI | 10.1002/14651858.cd009437.pub2 |
Pubmed ID | |
Authors |
Annemarije L Kruis, Nynke Smidt, Willem JJ Assendelft, Jacobijn Gussekloo, Melinde RS Boland, Maureen Rutten‐van Mölken, Niels H Chavannes |
Abstract |
In people with chronic obstructive pulmonary disease (COPD) there is considerable variation in symptoms, limitations and well-being, which often complicates medical care. To improve quality of life (QoL) and exercise tolerance, while reducing the number of exacerbations, a multidisciplinary program including different elements of care is needed. |
X Demographics
The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 11 | 30% |
Spain | 3 | 8% |
United States | 1 | 3% |
Belgium | 1 | 3% |
Netherlands | 1 | 3% |
Ecuador | 1 | 3% |
Unknown | 19 | 51% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 22 | 59% |
Practitioners (doctors, other healthcare professionals) | 9 | 24% |
Scientists | 4 | 11% |
Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 479 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | <1% |
United Kingdom | 3 | <1% |
United States | 3 | <1% |
Canada | 1 | <1% |
Netherlands | 1 | <1% |
Denmark | 1 | <1% |
Sweden | 1 | <1% |
Unknown | 465 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 95 | 20% |
Researcher | 69 | 14% |
Student > Ph. D. Student | 52 | 11% |
Student > Bachelor | 47 | 10% |
Other | 30 | 6% |
Other | 100 | 21% |
Unknown | 86 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 190 | 40% |
Nursing and Health Professions | 81 | 17% |
Social Sciences | 27 | 6% |
Psychology | 25 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 2% |
Other | 43 | 9% |
Unknown | 102 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2021.
All research outputs
#988,901
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#1,940
of 13,140 outputs
Outputs of similar age
#8,667
of 223,856 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 224 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 223,856 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.